Godsey & Gibb Inc’s Genmab GMAB Stock Holding History

Godsey & Gibb Inc’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$393	Buy	+11	New	+$348	﹤0.01%	485

Other funds holding GMAB

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return

TNAM

Terra Nova Asset Management New York $155M AUM 33.52% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

Godsey & Gibb Inc's GMAB Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Genmab (GMAB) in Q3 2026: 11 shares worth $393. The stake represents ﹤0.01% of the portfolio and ranks #485 among its holdings.

26 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

Godsey & Gibb Inc held 11 shares of Genmab worth $393 as of Q3 2026.
Genmab was a new Godsey & Gibb Inc position in Q3 2026.
Genmab made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #485 holding.
26 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.